Clinical Trials Directory

Trials / Completed

CompletedNCT07320170

Comparative Effects of CGF and PRP in Impacted Third Molar Surgery

Evaluation of the Effects of Platelet-rich Plasma and Concentrated Growth Factor on Postoperative Pain, Swelling, and Alveolar Osteitis After Mandibular Third Molar Surgery: a Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Recep Tayyip Erdogan University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of two different blood products obtained from the patient's own blood (Concentrated Growth Factor \[CGF\] and Platelet-Rich Plasma \[PRP\]) on healing after wisdom tooth extraction. The aim is to determine whether applying these materials to the extraction area reduces postoperative pain, facial swelling, and the risk of dry socket compared to standard healing.

Detailed description

This prospective, randomized, controlled clinical trial compares the efficacy of autologous platelet concentrates in reducing postoperative sequelae following the surgical extraction of impacted mandibular third molars. A total of 42 patients were randomly assigned to one of three groups: Control Group: Standard surgical extraction without additional biomaterials. CGF Group: Standard extraction followed by the placement of a CGF clot into the extraction socket. PRP Group: Standard extraction followed by submucosal injection of PRP. The primary outcome measured is postoperative pain (Visual Analog Scale) on postoperative days 1, 3, and 7. The secondary outcomes include facial swelling (linear measurements) on postoperative days 1, 3, and 7, and the incidence of alveolar osteitis (dry socket).

Conditions

Interventions

TypeNameDescription
BIOLOGICALConcentrated Growth Factor (CGF)Standard surgical extraction followed by the placement of a Concentrated Growth Factor (CGF) clot into the extraction socket immediately after tooth removal.
BIOLOGICALPlatelet-Rich Plasma (PRP)Standard surgical extraction followed by submucosal injection of Platelet-Rich Plasma (PRP) around the extraction site.

Timeline

Start date
2024-05-02
Primary completion
2025-05-02
Completion
2025-05-02
First posted
2026-01-06
Last updated
2026-01-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07320170. Inclusion in this directory is not an endorsement.